These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 8504413

  • 1. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
    Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP.
    Cancer Res; 1993 Jun 15; 53(12):2736-9. PubMed ID: 8504413
    [Abstract] [Full Text] [Related]

  • 2. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.
    Riemenschneider MJ, Büschges R, Wolter M, Reifenberger J, Boström J, Kraus JA, Schlegel U, Reifenberger G.
    Cancer Res; 1999 Dec 15; 59(24):6091-6. PubMed ID: 10626796
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.
    Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 15; 14(7):1774-83. PubMed ID: 16030116
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
    Waber PG, Chen J, Nisen PD.
    Cancer Res; 1993 Dec 15; 53(24):6028-30. PubMed ID: 8261417
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
    Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP.
    Cancer Res; 1996 Nov 15; 56(22):5141-5. PubMed ID: 8912848
    [Abstract] [Full Text] [Related]

  • 10. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP.
    Cancer Res; 2000 Jan 15; 60(2):417-24. PubMed ID: 10667596
    [Abstract] [Full Text] [Related]

  • 11. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O.
    J Natl Cancer Inst; 1994 Sep 07; 86(17):1297-302. PubMed ID: 8064888
    [Abstract] [Full Text] [Related]

  • 12. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
    Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B.
    Cancer Res; 1993 May 15; 53(10 Suppl):2231-4. PubMed ID: 8387391
    [Abstract] [Full Text] [Related]

  • 13. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
    Habuchi T, Kinoshita H, Yamada H, Kakehi Y, Ogawa O, Wu WJ, Takahashi R, Sugiyama T, Yoshida O.
    J Natl Cancer Inst; 1994 Sep 07; 86(17):1331-5. PubMed ID: 8064891
    [Abstract] [Full Text] [Related]

  • 14. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep 07; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 15. MDM2 gene amplification in metastatic osteosarcoma.
    Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH.
    Cancer Res; 1993 Jan 01; 53(1):16-8. PubMed ID: 8416741
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target.
    Riemenschneider MJ, Knobbe CB, Reifenberger G.
    Int J Cancer; 2003 May 10; 104(6):752-7. PubMed ID: 12640683
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas.
    Rieske P, Kordek R, Bartkowiak J, Debiec-Rychter M, Biernat W, Liberski PP.
    Pol J Pathol; 1998 May 10; 49(3):145-9. PubMed ID: 9810172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.